Posted on October 13, 202610/13/26
From PICO Planning to JCA Monitoring: Building Market Access Readiness in the EU JCA Era
Posted on September 25, 20269/25/26
Understanding the Role of AI in Government Pricing Compliance: New Risks and New Advantages
Posted on September 25, 20269/25/26
The Most-Favored-Nation Model, One Year Later: Where Do Globe, Guard, and Generous Stand Today?
Posted on September 25, 20269/25/26
CMS Bona Fide Service Fee Requirements: Manufacturer Challenges Under the CY 2026 Final Rule
Posted on June 4, 20266/4/26
Winning in the EU JCA Era: Why Proactive Intelligence Will Define Market Access Success
Posted on May 29, 20265/29/26
U.S. Drug Pricing Is Entering a More Complex Phase
Posted on May 8, 20265/8/26
How MFN is Reshaping Global Drug Pricing – and How NAVLIN Insights Tracks It
Posted on April 10, 20264/10/26
Stay Ahead of Change with NAVLIN Daily’s Global Policy Watch
Posted on March 9, 20263/9/26
Key Implications of Recent U.S. PBM Reforms
Posted on January 14, 20261/14/26